About Mimosa Diagnostics
Mimosa Diagnostics is a company based in Toronto (Canada) founded in 2016. The company has 13 employees as of December 31, 2024. Mimosa Diagnostics offers products and services including MIMOSA Pro. Mimosa Diagnostics operates in a competitive market with competitors including Podimetrics, Modulim, VOTIS, Thermetrix and OxiLight, among others.
- Headquarter Toronto, Canada
- Employees 13 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mimosa Diagnostics Usa Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Ontario Centre of Innovation
& 3 more
-
Employee Count
13
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mimosa Diagnostics
Mimosa Diagnostics offers a comprehensive portfolio of products and services, including MIMOSA Pro.
Assesses tissue health using near-infrared light for clinical monitoring.
People of Mimosa Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Mimosa Diagnostics
Investors in Mimosa Diagnostics
Mimosa Diagnostics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Ontario Centre of Innovation, Tidal Venture Partners and XDL Capital Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund investing in early-stage tech startups
|
Locked | Locked | Locked | |
|
Private equity firm focused on acquisitions & growth investments
|
Locked | Locked | Locked | |
|
MEDTEQ+ is focused on accelerating health technology innovation.
|
Locked | Locked | Locked |
Investor details for Mimosa Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mimosa Diagnostics
Investment portfolio details for Mimosa Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mimosa Diagnostics
Detailed financials for Mimosa Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mimosa Diagnostics Comparisons
Peer comparison for Mimosa Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mimosa Diagnostics
Mimosa Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Podimetrics, Modulim, VOTIS, Thermetrix and OxiLight, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diabetic foot ulcer monitoring device for patients and doctors
|
|
| Locked | Locked | Locked |
Non-invasive imaging devices for diabetic foot ulcer detection are provided.
|
|
| Locked | Locked | Locked |
AI-based device and platform for diagnosing diabetic patient feet
|
|
| Locked | Locked | Locked |
Medical device design and development company
|
|
| Locked | Locked | Locked |
Wound imaging solutions for diabetic foot ulcers and peripheral vascular disease
|
Detailed competitors of Mimosa Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mimosa Diagnostics
Complete news archive for Mimosa Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mimosa Diagnostics
Mimosa Diagnostics was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Mimosa Diagnostics is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
As of Dec 31, 2024, the latest employee count at Mimosa Diagnostics is 13.
Founded in 2016 in Toronto, Canada, Mimosa Diagnostics operates in the mHealth sector, focusing on applications and devices for remote monitoring of diabetic foot health. Photographs captured under near-infrared light are utilized to enhance visibility of tissue-related molecules, enabling ulcer detection before naked-eye observation. This approach supports healthcare practitioners in managing patient care remotely.
Mimosa Diagnostics's top competitors include Podimetrics, Modulim and VOTIS.
Mimosa Diagnostics offers MIMOSA Pro.
Mimosa Diagnostics has 4 investors. Key investors include Ontario Centre of Innovation, Tidal Venture Partners, XDL Capital Group, and MEDTEQ+.